Aetna (AET) Tops Q3 EPS by 37c, Miss on Revenues; Offers FY17 EPS Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Aetna (AET) PT Raised to $192 at Morgan Stanley
November 1, 2017 8:51 AM EDTMorgan Stanley raised its price target on Aetna (NYSE: AET) to $192.00 (from $179.00) while maintaining a Overweight rating following results.
... MoreAetna (AET) PT Raised to $185 at Jefferies
November 1, 2017 8:00 AM EDTJefferies raised its price target on Aetna (NYSE: AET) to $185.00 (from $165.00) while maintaining a Hold rating.
Analyst David Windley listed 4 key insights from the quarter:
1. Strong, Well Balanced Results.
2. Repositioning or Dressing Up
3. Conservative MLR; We Are 2% > 2017 EPS Guidance.
4.... More
CVS deal for Aetna could help retailer face Amazon entry: analysts
October 27, 2017 9:47 AM EDTBy Ankur Banerjee
(Reuters) - U.S. pharmacy operator CVS Health Corp's (NYSE: CVS) move to buy health insurer Aetna Inc (NYSE: AET) could shore-up CVS' vulnerable pharmacy business and spur another round of dealmaking in an industry fearing Amazon's arrival, analysts said.
Shares of Aetna, the third-largest U.S. health insurer, closed down 3 percent on Friday after closing 12 percent higher on Thursday on reports of the deal. CVS Health was down 5.9 percent.
CVS Health has made an offer to acquire... More
CVS Health (CVS): Aetna Would Be An Extension Of Its Prior Acquisition Strategy - Guggenheim
October 27, 2017 7:24 AM EDTGuggenheim analyst, John Heinbockel, reiterated his Buy rating on shares of CVS Health (NYSE: CVS) after media reports state the company is is in talks to acquire Aetna (NYSE: AET) for more than $200 per share.... More
Cantor Fitzgerald Downgrades Aetna (AET) to Neutral
October 27, 2017 3:17 AM EDTCantor Fitzgerald downgraded Aetna (NYSE: AET) from Overweight to Neutral with a price target of $175.00.
Analyst Steven Halper cites speculation that CVS would buy the company for the downgrade noting the offer price is just above his PT and he believes the... More
